Metsera (NASDAQ:MTSR) Posts Quarterly Earnings Results

Metsera (NASDAQ:MTSR) posted its quarterly earnings data on Monday. The company reported ($1.03) earnings per share for the quarter, Zacks reports.

Metsera Stock Performance

Metsera stock opened at $23.88 on Monday. Metsera has a one year low of $12.30 and a one year high of $32.81. The firm’s fifty day simple moving average is $22.80.

Analyst Ratings Changes

A number of research firms have recently commented on MTSR. Cantor Fitzgerald initiated coverage on Metsera in a research note on Tuesday, February 25th. They issued an “overweight” rating on the stock. Guggenheim started coverage on shares of Metsera in a research report on Tuesday, February 25th. They set a “buy” rating and a $56.00 price objective on the stock. Evercore ISI started coverage on shares of Metsera in a research note on Tuesday, February 25th. They set an “outperform” rating for the company. Finally, Bank of America assumed coverage on shares of Metsera in a research note on Tuesday, February 25th. They issued a “buy” rating and a $38.00 target price on the stock.

Metsera Company Profile

Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.